1. A shrinkage estimator for subgroup analysis without the exchangeability assumption. Issue 6 (2nd November 2021) Authors: Snapinn, Steven Journal: Journal of biopharmaceutical statistics Issue: Volume 31:Issue 6(2021) Page Start: 723 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Choosing Appropriate Metrics to Evaluate Adverse Events in Safety Evaluation. (May 2015) Authors: Zhou, Ying; Ke, Chunlei; Jiang, Qi; Shahin, Seta; Snapinn, Steven Journal: Therapeutic innovation & regulatory science Issue: Volume 49:Number 3(2015:May) Page Start: 398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Content Validity of HIT‐6 as a Measure of Headache Impact in People With Migraine: A Narrative Review. Issue 1 (6th December 2019) Authors: Houts, Carrie R.; Wirth, R.J.; McGinley, James S.; Gwaltney, Chad; Kassel, Eric; Snapinn, Steven; Cady, Roger Journal: Headache Issue: Volume 60:Issue 1(2020) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. On Errors in Stratified Randomization. (3rd April 2017) Authors: Ke, Chunlei; Wang, Jianming; Zhang, Charlie; Jiang, Qi; Snapinn, Steven Journal: Statistics in biopharmaceutical research Issue: Volume 9:Number 2(2017) Page Start: 225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Remaining Challenges in Assessing Non-Inferiority. (January 2014) Authors: Snapinn, Steven; Jiang, Qi Journal: Therapeutic innovation & regulatory science Issue: Volume 48:Number 1(2014:Jan.) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Responsibilities of Data Monitoring Committees: Consensus Recommendations. (September 2016) Authors: Bierer, Barbara E.; Li, Rebecca; Seltzer, Jonathan; Sleeper, Lynn A.; Frank, Elizabeth; Knirsch, Charles; Aldinger, Carmen E.; Levine, Robert J.; Massaro, Joe; Shah, Amish; Barnes, Mark; Snapinn, Steven; Wittes, Janet Journal: Therapeutic innovation & regulatory science Issue: Volume 50:Number 5(2016:Sep.) Page Start: 648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Some remaining challenges regarding multiple endpoints in clinical trials. (30th June 2017) Authors: Snapinn, Steven Journal: Statistics in medicine Issue: Volume 36:Number 28(2017) Page Start: 4441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Statistical Considerations on the Evaluation of Imbalances of Adverse Events in Randomized Clinical Trials. (November 2015) Authors: Ma, Haijun; Ke, Chunlei; Jiang, Qi; Snapinn, Steven Journal: Therapeutic innovation & regulatory science Issue: Volume 49:Number 6(2015:Nov.) Page Start: 957 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Treatment effect measures under nonproportional hazards. (6th October 2022) Authors: Snapinn, Steven; Jiang, Qi; Ke, Chunlei Journal: Pharmaceutical statistics Issue: Volume 22:Number 1(2023) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding data and safety monitoring committees in clinical trials (morning panel session). (August 2018) Authors: Davis, Barry; Kerr, David; Maguire, Maureen; Sanders, Corsee; Snapinn, Steven; Wittes, Janet Journal: Clinical trials Issue: Volume 15:Number 4(2018) Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗